COVID-19 and Cardiovascular Disease
| Autor: | Tamanna Singh, John C. Tilton, Joseph Loscalzo, John Barnard, Emily J. Tsai, Scott J. Cameron, Mina K. Chung, Deborah H. Kwon, David A. Zidar, Nathan R. Tucker, Timothy A. Chan, Clifford V. Harding, Michael R. Bristow |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
0301 basic medicine
medicine.medical_specialty Physiology business.industry Inflammation Disease 030204 cardiovascular system & hematology medicine.disease Thrombosis 03 medical and health sciences 030104 developmental biology 0302 clinical medicine Immune system Pandemic Epidemiology Immunology medicine Platelet activation medicine.symptom Cardiology and Cardiovascular Medicine Ventricular remodeling business |
| Zdroj: | Circulation Research. 128:1214-1236 |
| ISSN: | 1524-4571 0009-7330 |
| Popis: | A pandemic of historic impact, coronavirus disease 2019 (COVID-19) has potential consequences on the cardiovascular health of millions of people who survive infection worldwide. Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2), the etiologic agent of COVID-19, can infect the heart, vascular tissues, and circulating cells through ACE2 (angiotensin-converting enzyme 2), the host cell receptor for the viral spike protein. Acute cardiac injury is a common extrapulmonary manifestation of COVID-19 with potential chronic consequences. This update provides a review of the clinical manifestations of cardiovascular involvement, potential direct SARS-CoV-2 and indirect immune response mechanisms impacting the cardiovascular system, and implications for the management of patients after recovery from acute COVID-19 infection. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|